BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12015467)

  • 1. Group B streptococci during pregnancy and infancy.
    Berner R
    Curr Opin Infect Dis; 2002 Jun; 15(3):307-13. PubMed ID: 12015467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance, management and prevention of Streptococcus agalactiae infection during the perinatal period.
    Berner R
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):427-37. PubMed ID: 15482207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.
    Vornhagen J; Adams Waldorf KM; Rajagopal L
    Trends Microbiol; 2017 Nov; 25(11):919-931. PubMed ID: 28633864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable?
    Gilbert GL
    Expert Rev Vaccines; 2004 Aug; 3(4):371-4. PubMed ID: 15270637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of perinatal group B streptococcal disease.
    Baker CJ
    Vaccine; 2013 Aug; 31 Suppl 4():D3-6. PubMed ID: 23973344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: Addressing the challenge of group B streptococcal disease.
    Rappuoli R; Black S
    Vaccine; 2013 Aug; 31 Suppl 4():D1-2. PubMed ID: 23973341
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
    Schrag SJ; Verani JR
    Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for
    Pena JMS; Lannes-Costa PS; Nagao PE
    Front Immunol; 2024; 15():1430901. PubMed ID: 38947337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on vaccination against group B streptococcus.
    Heath PT
    Expert Rev Vaccines; 2011 May; 10(5):685-94. PubMed ID: 21604988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cell adherence of group B streptococci from preterm infants with neonatal sepsis.
    Helmig R; Halaburt JT; Uldbjert N; Thomsen AC; Stenderup A
    Obstet Gynecol; 1990 Nov; 76(5 Pt 1):825-7. PubMed ID: 2216233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A maternal vaccine against group B Streptococcus: past, present, and future.
    Chen VL; Avci FY; Kasper DL
    Vaccine; 2013 Aug; 31 Suppl 4(0 4):D13-9. PubMed ID: 23973342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of group B streptococcal infection.
    Noya FJ; Baker CJ
    Infect Dis Clin North Am; 1992 Mar; 6(1):41-55. PubMed ID: 1578122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive group B streptococcal infections in infants, France.
    Poyart C; Réglier-Poupet H; Tazi A; Billoët A; Dmytruk N; Bidet P; Bingen E; Raymond J; Trieu-Cuot P
    Emerg Infect Dis; 2008 Oct; 14(10):1647-9. PubMed ID: 18826837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and management of infants with suspected or proven neonatal sepsis.
    Brady MT; Polin RA
    Pediatrics; 2013 Jul; 132(1):166-8. PubMed ID: 23753101
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
    Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
    Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for term and late preterm infants at risk for perinatal bacterial infection.
    Stocker M; Berger C; McDougall J; Giannoni E;
    Swiss Med Wkly; 2013; 143():w13873. PubMed ID: 24089151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence of strains of new types and type candidates of group B streptococci (Streptococcus agalactiae). Comparative evaluation using mice and a chicken embryo model.
    Wagner M; Kaatz M
    Adv Exp Med Biol; 1997; 418():819-21. PubMed ID: 9331778
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
    Verani JR; McGee L; Schrag SJ;
    MMWR Recomm Rep; 2010 Nov; 59(RR-10):1-36. PubMed ID: 21088663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group B streptococcus late-onset disease: 2003-2010.
    Berardi A; Rossi C; Lugli L; Creti R; Bacchi Reggiani ML; Lanari M; Memo L; Pedna MF; Venturelli C; Perrone E; Ciccia M; Tridapalli E; Piepoli M; Contiero R; Ferrari F;
    Pediatrics; 2013 Feb; 131(2):e361-8. PubMed ID: 23296441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.